Complement Inhibition: A Novel Form of Immunotherapy for Colon Cancer.

Volume: 23, Issue: 2, Pages: 655 - 662
Published: Feb 1, 2016
Abstract
Complement is a central part of both the innate and adaptive immune response and its activation has traditionally been considered part of the immunosurveillance response against cancer. Its pro-inflammatory role and its contribution to the development of many illnesses associated with inflammatory states implicate complement in carcinogenesis. We evaluated the role of three protein inhibitors of complement—cobra venom factor, humanized cobra...
Paper Details
Title
Complement Inhibition: A Novel Form of Immunotherapy for Colon Cancer.
Published Date
Feb 1, 2016
Volume
23
Issue
2
Pages
655 - 662
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.